ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,203.70
0.95%
S&P ASX All Technology
3,433.00
1.97%
Brent Oil
71.025
-2.96%
US Dollar vs AUD
1.45009
-1.08%
Bitcoin
65,213.00
3.29%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Daxor Corporation (DXR)

  7. Daxor Corporation (DXR) News

DXR

Daxor (DXR)

Daxor Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DXR
DateTimeSourceHeadlineSymbolCompany
19/09/202422:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024NASDAQ:DXRDaxor Corporation
12/09/202422:00GlobeNewswire Inc.Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome ManagementNASDAQ:DXRDaxor Corporation
05/09/202422:00GlobeNewswire Inc.Daxor Corporation Receives $300K Matching Fund Award From Launch TennesseeNASDAQ:DXRDaxor Corporation
04/09/202422:30GlobeNewswire Inc.Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient CareNASDAQ:DXRDaxor Corporation
04/09/202406:05GlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder LetterNASDAQ:DXRDaxor Corporation
04/09/202402:15GlobeNewswire Inc.Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:DXRDaxor Corporation
30/08/202407:27Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
30/08/202407:16Edgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualNASDAQ:DXRDaxor Corporation
29/08/202422:00GlobeNewswire Inc.Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated NetworkNASDAQ:DXRDaxor Corporation
24/08/202406:52Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]NASDAQ:DXRDaxor Corporation
17/08/202407:23Edgar (US Regulatory)Form N-2 - Registration statement for closed-end investment companiesNASDAQ:DXRDaxor Corporation
06/08/202422:00GlobeNewswire Inc.Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
05/08/202422:00GlobeNewswire Inc.Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum NationwideNASDAQ:DXRDaxor Corporation
24/07/202422:00GlobeNewswire Inc.Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
19/07/202404:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
18/07/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
18/07/202407:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
18/07/202407:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
18/07/202407:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
11/07/202422:00GlobeNewswire Inc.Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction NationwideNASDAQ:DXRDaxor Corporation
18/06/202422:00GlobeNewswire Inc.Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual MeetingNASDAQ:DXRDaxor Corporation
06/06/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
05/06/202422:00GlobeNewswire Inc.Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical OfficerNASDAQ:DXRDaxor Corporation
30/05/202420:43Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
16/04/202422:00GlobeNewswire Inc.New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionNASDAQ:DXRDaxor Corporation
15/04/202422:00GlobeNewswire Inc.DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)NASDAQ:DXRDaxor Corporation
10/04/202422:00GlobeNewswire Inc.Daxor Corporation Announces New Hospital Account at Leading Chicago HospitalNASDAQ:DXRDaxor Corporation
01/04/202423:00GlobeNewswire Inc.Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24NASDAQ:DXRDaxor Corporation
25/03/202423:00GlobeNewswire Inc.Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsNASDAQ:DXRDaxor Corporation
22/03/202423:00GlobeNewswire Inc.Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024NASDAQ:DXRDaxor Corporation
 Showing the most relevant articles for your search:NASDAQ:DXR

Your Recent History

FTSE
UKX
FTSE 100
ASX
NCM
Newcrest Mining
ASX
XTO
S&P ASX 100
ASX
RIO
Rio Tinto
COIN
ADAUSD
Cardano
ASX
CSL
CSL
ASX
TLS
Telstra
ASX
XJO
S&P ASX 200
COIN
XRPUSD
Ripple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
SUN
Suncorp
NASDAQ
AMZN
Amazon.com
ASX
WDC
Westfield
COIN
SOLUSD
Solana
FX
AUDUSD
AUD vs US Dollar
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved